The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2020
Filed:
Jan. 20, 2016
Applicants:
Incarda Therapeutics, Inc., Palo Alto, CA (US);
The Regents of the University of California, Oakland, CA (US);
Inventors:
Rangachari Narasimhan, Saratoga, CA (US);
Gregory Marcus, San Francisco, CA (US);
Assignees:
InCarda Therapeutics, Inc., Newark, CA (US);
The Regents of the University of California, Oakland, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61P 7/02 (2006.01); A61K 9/00 (2006.01); A61K 31/4709 (2006.01); A61K 31/727 (2006.01); A61K 31/4365 (2006.01); A61K 31/616 (2006.01); A61K 31/37 (2006.01); A61K 31/4465 (2006.01); A61K 38/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0078 (2013.01); A61K 9/008 (2013.01); A61K 9/0075 (2013.01); A61K 31/37 (2013.01); A61K 31/4365 (2013.01); A61K 31/4465 (2013.01); A61K 31/4709 (2013.01); A61K 31/616 (2013.01); A61K 31/727 (2013.01); A61K 38/12 (2013.01); A61K 9/007 (2013.01); A61P 7/02 (2018.01);
Abstract
Disclosed herein are methods for prophylactic treatment of acute coronary syndrome (ACS) comprising administering, by inhalation, an effective amount of a pharmaceutical composition comprising at least one anticoagulant or antiplatelet agent to a subject in need thereof, wherein the anticoagulant or antiplatelet agent first enters the heart via the left atrium.